On September 1, 2021, Junli He, the Executive Vice Chairman of Bright Scholar Holdings, joined the Board of Directors (the Board) of Biostage, Inc. as a Class I director. The appointment to the Board was effective immediately. As a Class I director, the initial term of Mr. He as director will run until the Company's 2023 annual meeting of stockholders and until his successor is duly elected and qualified, or until his resignation or removal.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | -14.18% | -0.86% | -53.91% |
1st Jan change | Capi. | |
---|---|---|
-53.91% | 32.92M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.30% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Biostage, Inc. Appoints Junli He as Class I Director